New Jersey S 3336: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2019-01-17)

State: New Jersey · Session: 218 · Bill: S 3336

Subjects: PHARMACEUTIC

Sponsors: Singleton, Troy, Greenstein, Linda R.

View New Jersey S 3336 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.